On Demand Webinar: Formulation of Biologics for Inhalation Products

Learn more about the challenges or repurposing existing parenteral biologic products for inhaled and nasal delivery to improve patient experiences and reduce complications.

Biopharmaceuticals are a vital part of modern pharmaceutical development; however, they are susceptible to a range of aggregation and degradation pathways which make the manufacture, processing and delivery of these products more challenging than more typical small molecules. The majority of biologics are delivered parenterally, however inhaled and nasal delivery allows for a more convenient method of administering compounds systemically, and also allows direct targeting of the respiratory system.

This webinar will cover industry trends and take a look at the challenges of repurposing existing parenteral products for inhaled and nasal delivery to improve patient experiences and reduce complications from routine IV delivery. It will cover suitable excipient strategies, manufacturing processes and analytical challenges, as well as looking at device compatibility. Real world case studies show how effective formulations can be developed by bringing together techniques for inhaled and biologic product development.

Access our On Demand Webinar: Formulation of Biologics for Inhalation Products by completing the form below.